Health Update: Successful trial of 'mRNA' vaccine! Prevent cancer again; Decreased risk of melanoma spreading throughout the body
Personalized mRNA developed by Moderna and Merck Cancer The vaccine has been successful in late-stage clinical trials in high-risk melanoma patients. The vaccine was given along with Merck's immunotherapy drug Keytuda. This personalized mRNA vaccine has been developed to reduce the risk of melanoma returning or spreading to other parts of the body after surgery. … Read more